What is Araya Zaesim's NPI number?

Araya Zaesim's National Provider Identifier (NPI) is 1588142517, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Araya Zaesim's specialty?

Araya Zaesim is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Araya Zaesim located?

Araya Zaesim's practice location on file with NPPES is 3265 Ne Ralph Powell Rd, Lees Summit, MO 64064-2301.

What is Araya Zaesim's phone number?

The practice phone number listed in the NPPES registry for Araya Zaesim is (816) 454-3424.

Does Araya Zaesim accept Medicare?

Araya Zaesim is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Araya Zaesim's NPI active?

Yes — Araya Zaesim's NPI (1588142517) is active in the NPPES registry as of the last update on 2025-12-01.

IndividualActiveAccepts Medicare

Araya Zaesim, MD

NPI 1588142517 · Dermatology Physician · Lees Summit, MO

Araya Zaesim, MD is a Dermatology Physician provider in Lees Summit, MO (NPI 1588142517).

Provider details

NPI number: 1588142517
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Male
Sole proprietor: No
License: 04-48094 (KS)

Practice location

3265 Ne Ralph Powell Rd

Lees Summit, MO 64064-2301

Phone: (816) 454-3424

Street-level locationGet directions

More MO providers

Mailing address

7901 W 135th St

Overland Park, KS 66223-1201

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 2023031523 (MO)
Allopathic & Osteopathic Physicians
Dermatology Physician207N00000XLicense 04-48094 (KS)
Allopathic & Osteopathic Physicians

Additional practice locations (1)

7901 W 135th St
Overland Park, KS 66223-1201
Phone: (913) 754-5091

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(63/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
8 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
2 documented practice locations
Medicare service volume (vs. specialty peers)25% of score
1,642 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	581	$6
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	222	$121
Destruction of Precancer Skin Growth, 1 Growth17000	202	$52
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	186	$86
Destruction of Skin Growth, 1-14 Growths17110	102	$105
New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 16 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Triamcinolone Acetonide	215	149
Clobetasol Propionate	152	88
Ketoconazole	95	50
Doxycycline Hyclate	71	39
Clindamycin Phosphate	45	30
Hydrocortisone	39	22
Metronidazole	28	15
Dupilumabbrand: Dupixent Pen

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,975 across 158 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2018-08-01
Last updated: 2025-12-01
Certified: 2025-12-01

Frequently asked questions

What is Araya Zaesim's NPI number?: Araya Zaesim's National Provider Identifier (NPI) is 1588142517, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Araya Zaesim's specialty?: Araya Zaesim is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Araya Zaesim located?: Araya Zaesim's practice location on file with NPPES is 3265 Ne Ralph Powell Rd, Lees Summit, MO 64064-2301.
What is Araya Zaesim's phone number?: The practice phone number listed in the NPPES registry for Araya Zaesim is (816) 454-3424.
Does Araya Zaesim accept Medicare?: Araya Zaesim is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Araya Zaesim's NPI active?: Yes — Araya Zaesim's NPI (1588142517) is active in the NPPES registry as of the last update on 2025-12-01.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	581	$6
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	222	$121
Destruction of Precancer Skin Growth, 1 Growth17000	202	$52
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	186	$86
Destruction of Skin Growth, 1-14 Growths17110	102	$105
New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More

Drug

Part D claims (2024)

Beneficiaries

Triamcinolone Acetonide

215

149

Clobetasol Propionate

152

Ketoconazole

Doxycycline Hyclate

Clindamycin Phosphate

Hydrocortisone

Metronidazole

Dupilumabbrand: Dupixent Pen

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,975 across 158 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Additional practice locations (1)

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Additional practice locations (1)

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments